parkinson-disease

Documents about parkinson-disease

• Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease#857271ClinicalTrials.gov
• Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease#855759ClinicalTrials.gov
• Head-up Tilt Sleeping to Alleviate Orthostatic Hypotension, Supine Hypertension and Nocturia in Parkinson's Disease#356590ClinicalTrials.gov
• The Efficacy of a Remote Cognitive Remediation Therapy (CRT) Program on Parkinson's Disease#801451ClinicalTrials.gov
• Effect of SpiroGym App in Patients With Parkinson's Disease#801915ClinicalTrials.gov
• REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study#808100ClinicalTrials.gov
• Microbiome Composition and Function Contributes to Cognitive Impairment and Neuroinflammation in Parkinson's Disease#810274ClinicalTrials.gov
• Motor Adaptation to Split-Belt Treadmill in Parkinson's Disease#811359ClinicalTrials.gov
• Effect of Levodopa on Postural Motor Learning in Parkinson Disease#813503ClinicalTrials.gov
• Remifentanil Requirement in Patients Receiving Surgical Treatment of Parkinson's Disease#830785ClinicalTrials.gov
• Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients#835230ClinicalTrials.gov
• Efficacy of Voice Treatment for Parkinson's Disease#835676ClinicalTrials.gov
• Effects of Vitamin D in Parkinson's Disease (PD)#836964ClinicalTrials.gov
• Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia#838620ClinicalTrials.gov
• Evaluation of the Efficacy and Safety of Fecal Microbiota Transplantation for Constipation in Parkinson's Disease#839976ClinicalTrials.gov
• Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations#845160ClinicalTrials.gov
• Impact of C-Mill Rehabilitation on the Gut-Brain Axis in Parkinson's Disease#845294ClinicalTrials.gov
• Flexible vs. Standard Deep Brain Stimulation Programming in Parkinson Disease Patients#848849ClinicalTrials.gov
• Simpler and Safer Deep Brain Stimulation for Parkinson's Disease#856091ClinicalTrials.gov
• Differences Between Patients With Vascular Parkinsonism and Parkinson's Disease#858651ClinicalTrials.gov
• Estimates of the Short-term Efficacy of Talineuren (TLN) and Placebo in Patients With Parkinson Disease#862343ClinicalTrials.gov
• Interactive Home-based Rehabilitation Exercise Assessment Platform and Exploration of Clinical Effects in Patients with Parkinson's Disease#859333ClinicalTrials.gov
• The Effects of Specific tDCS on Cognition in MCI#860797ClinicalTrials.gov
• The Role of EEG in Identifying Cognitive Changes in Parkinson's Disease#824830ClinicalTrials.gov
• Study of Transanal Irrigation vs Standard Care for Constipation, Gut Microbiota, and Motor Disorders in Parkinson's Disease#848699ClinicalTrials.gov
• Using [18F]FDOPA PET/CT to Monitor the Effectiveness of Fetal Dopaminergic Grafts in Parkinson Disease Patients#860863ClinicalTrials.gov
• Assessment of Methods Used in Evaluating Balance Rehabilitation in Parkinson's Patients#861536ClinicalTrials.gov
• Dysphagia and Dysphonia in Parkinson’s Disease: Pathophysiological Mechanisms, Treatment Approaches, and Clinical Implications#179606OSF
• Quantitative Assessment of Visible Nigrosome-1 in Patients with Parkinson's Disease#642416Europe PMC
• A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease#803661ClinicalTrials.gov
• A Clinical Study of IRL790 in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia#827364ClinicalTrials.gov
• Telemedicine Intervention to Improve Physical Function#832289ClinicalTrials.gov
• Virtual Reality Effects on Functional Capacity and Quality of Life of People With Parkinson's Disease#837936ClinicalTrials.gov
• Study Investigating Effects of Foliglurax in Patients With Parkinson's Disease (PD) and Healthy Subjects#841163ClinicalTrials.gov
• Tandem DBS for Parkinson's Disease: A Pilot Study Utilizing STN/GPi + Hypothalamic Stimulation#848422ClinicalTrials.gov
• National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial#851760ClinicalTrials.gov
• Retinal Biomarkers in Parkinson´s Disease#852084ClinicalTrials.gov
• Evaluation of Neurocognitive Changes in Parkinson's Disease After Low Frequency Burst Stimulation#854148ClinicalTrials.gov
• Electro-acupuncture for Gait and Balance in Parkinson's Disease#855879ClinicalTrials.gov
• Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease#858817ClinicalTrials.gov
• rTMS for Motor and Mood Symptoms of Parkinson's Disease#859443ClinicalTrials.gov
• Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease#859776ClinicalTrials.gov
• Exploration of the Reward System by Functional MRI in Parkinson's Disease Patients With and Without REM Sleep Behavior Disorder#836804ClinicalTrials.gov
• Current potential biomarkers for Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis: review of literature#4659Europe PMC
• Genetic landscape of Parkinson's disease in the Personalized Parkinson Project cohort#67980bioRxiv / medRxiv
• Guideline for Hometitration With Duodopa for Parkinson Patients#833499ClinicalTrials.gov
• Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype Correlation#806768ClinicalTrials.gov
• Caffeine for Motor Manifestations of Parkinson's Disease#831515ClinicalTrials.gov
• Behavioral Intervention for Lifestyle Physical Activity in Parkinson's Disease#844224ClinicalTrials.gov
• Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients#856567ClinicalTrials.gov